NO954736L - Fluorholdige makrosykliske metallkomplekser - Google Patents

Fluorholdige makrosykliske metallkomplekser

Info

Publication number
NO954736L
NO954736L NO954736A NO954736A NO954736L NO 954736 L NO954736 L NO 954736L NO 954736 A NO954736 A NO 954736A NO 954736 A NO954736 A NO 954736A NO 954736 L NO954736 L NO 954736L
Authority
NO
Norway
Prior art keywords
pct
metal complexes
fluorine
agents
macrocyclic metal
Prior art date
Application number
NO954736A
Other languages
English (en)
Other versions
NO954736D0 (no
NO301983B1 (no
Inventor
Johannes Platzek
Bernd Raduchel
Ulrich Niedballa
Hanns-Joachim Weinmann
Hans Bauer
Klaus Roth
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO954736L publication Critical patent/NO954736L/no
Publication of NO954736D0 publication Critical patent/NO954736D0/no
Publication of NO301983B1 publication Critical patent/NO301983B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4804—Spatially selective measurement of temperature or pH

Landscapes

  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Signal Processing (AREA)
  • Radiology & Medical Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO954736A 1993-05-24 1995-11-23 Fluorholdige makrosykliske metallkomplekser, diagnostiske midler inneholdende slike samt deres anvendelse i NMR-spektroskopi NO301983B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4317588A DE4317588C2 (de) 1993-05-24 1993-05-24 Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
PCT/EP1994/001377 WO1994027978A1 (de) 1993-05-24 1994-04-29 Fluorhaltige makrocyclische metallkomplexe

Publications (3)

Publication Number Publication Date
NO954736L true NO954736L (no) 1995-11-23
NO954736D0 NO954736D0 (no) 1995-11-23
NO301983B1 NO301983B1 (no) 1998-01-05

Family

ID=6489003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954736A NO301983B1 (no) 1993-05-24 1995-11-23 Fluorholdige makrosykliske metallkomplekser, diagnostiske midler inneholdende slike samt deres anvendelse i NMR-spektroskopi

Country Status (11)

Country Link
US (1) US5690909A (no)
EP (1) EP0700393B1 (no)
JP (1) JPH08511248A (no)
AT (1) ATE159522T1 (no)
CA (1) CA2163643A1 (no)
DE (2) DE4317588C2 (no)
DK (1) DK0700393T3 (no)
ES (1) ES2110753T3 (no)
GR (1) GR3025610T3 (no)
NO (1) NO301983B1 (no)
WO (1) WO1994027978A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1265440B1 (it) * 1993-12-24 1996-11-22 Bracco Spa Formulazioni diagnostiche paramagnetiche e metodo d'uso delle stesse
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6180113B1 (en) * 1996-02-23 2001-01-30 Schering Ag Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
EP1088559A3 (de) * 1999-09-29 2002-10-02 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN Galenische Formulierungen
GB0009353D0 (en) * 2000-04-14 2000-05-31 Nycomed Imaging As Method
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
NO20015814D0 (no) * 2001-11-28 2001-11-28 Amersham Health As Metallkompleksforbindelser
FR2857967B1 (fr) * 2003-07-25 2015-04-24 Centre Nat Rech Scient Complexes de lanthanide, leur preparation et leurs utilisations
DE102005033902B3 (de) * 2005-07-15 2007-04-05 Schering Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102005033903B4 (de) * 2005-07-15 2007-08-09 Bayer Schering Pharma Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102006049821A1 (de) * 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
GB0708411D0 (en) * 2007-05-01 2007-06-06 Univ Durham Lanthanide probes
WO2009113704A2 (en) * 2008-03-11 2009-09-17 Kyoto University Fluorine-containing compound and method for detecting biomolecule using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
DE3625417C2 (de) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
WO1989000557A1 (en) * 1987-07-16 1989-01-26 Cockbain, Julian, Roderick, Michaelson Aminopolycarboxylic acids and derivatives thereof
DE3927444A1 (de) * 1989-08-16 1991-02-28 Schering Ag Verwendung von amid-komplexverbindungen
AU625529B2 (en) * 1989-12-22 1992-07-16 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
AU6709390A (en) * 1989-12-22 1991-06-27 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-tris-carboxymethyl -1,4,7,10-tetraazacyclododecane
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4115789A1 (de) * 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4140779A1 (de) * 1991-12-06 1993-06-09 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Verfahren zur herstellung von mono-n-substituierten tetraazamakrocyclen
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe

Also Published As

Publication number Publication date
EP0700393A1 (de) 1996-03-13
EP0700393B1 (de) 1997-10-22
DE4317588A1 (de) 1994-12-01
DE4317588C2 (de) 1998-04-16
US5690909A (en) 1997-11-25
DK0700393T3 (da) 1998-07-20
WO1994027978A1 (de) 1994-12-08
NO954736D0 (no) 1995-11-23
CA2163643A1 (en) 1994-12-08
DE59404438D1 (de) 1997-11-27
ES2110753T3 (es) 1998-02-16
NO301983B1 (no) 1998-01-05
GR3025610T3 (en) 1998-03-31
ATE159522T1 (de) 1997-11-15
JPH08511248A (ja) 1996-11-26

Similar Documents

Publication Publication Date Title
ATE159522T1 (de) Fluorhaltige makrocyclische metallkomplexe
ATE222244T1 (de) Mono -und multimere verbindungen mit erhöhter relaxation
ZA9410281B (en) Metal complexes of dendrimeric macromolecules diagnostic agents containing the latter as well as process for the production of the complexes and agents
ES2091323T3 (es) Medios de contraste.
DE69425572D1 (de) Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
ATE174331T1 (de) Verwendung von makrocyclischen metallkomplexen als temperatursonden
DK0680464T3 (da) Derivatiserede DTPA-komplekser, farmaceutiske midler indeholdende disse forbindelser, deres anvendelse som NMR- og røntgenkontrastmidler og fremgangsmåde til fremstilling af forbindelserne
IL114858A0 (en) DTPA derivatives metal complexes thereof pharmaceutical and diagnostic agents containing the same and methods for the preparation thereof
NO962243L (no) Halogenarylsubstituerte metallkomplekser, farmasöytiske midler inneholdende slike og deres anvendelse i diagnostikken, samt fremgangsmåte for fremstilling av slike komplekser og midler
ATE178592T1 (de) Iodierte röntgenkontrastmittel